Custom Enquiry
We aim to give you a response from a qualified scientist within a hour.
Product Details
Formula
C17H12I2O3
MW
518.09
Purity
>97%
Solubility (DMSO Mg/MI)
5
Storage (Powder)
3 Years -20°C
Storage (Solvent)
1 Year -80°C
Indication
N/A
Mode Of Action
inhibitor
Drug Status
Withdrawn from market
Target Name
Cytochrome P-450 CYP2C9
Research Area
OTHER
Research Area Sub Group
uricosuric
Pharmacology
ENZYMES
Pharmacology Area Sub Group
Oxygenases
Bio Chemical Notes
Benziodarone has been used in the treatment of those with hyperuricemia and gout. An analogue of Benzbromarone which is a very potent inhibitor of CYP2C9. Ref: Drug Metabolism and Disposition. 2003; 31 (7), 967-971.